The Report Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product
[Therapeutic (PAP, Oral, Nasal, Chin), Diagnostic (Respiratory Polygraphs,
Actigraph, Polysomnography, Pulse Oximeters)], By Region, 2019 – 2025
The global sleep apnea devices market size is estimated
to be worth USD 12.61 billion by 2025, expanding at a CAGR of 6.8% from 2019 to
2025, according to a report by Grand View Research, Inc. Increasing number of
patients suffering from sleep apnea, growing awareness, and treatment rate of
these diseases in North America are some of the factors contributing to the
revenue growth.
On the basis of product type, the market is categorized into
therapeutic and diagnostic devices. Therapeutic device led the market with
about 65.06% of revenue share in 2018, due to increased awareness and patient
medication adherence in developed markets such as U.S. and Canada and high
prevalence of Obstructive Sleep Apnea (OSA). PAP Devices led the therapeutic
segment due to higher product adoption and availability and comparative higher
patient outcome. The segment is expected to witness a CAGR of 5.1% between 2019
and 2025.
Diagnostic device segment comprises of actigraphs,
polysomnography, respiratory polygraphs, and pulse oximeters. Polysomnography
devices led the market with 34.88% of revenue share in 2018 and is estimated to
witness a CAGR of 7.05% over the forecast period. As there is no gold standard
for diagnosis of OSA, polysomnography is one of the most preferred diagnostic
tests for sleep apnea. Increase in preference of polysomnography test is
expected to drive the market revenue between 2019 and 2025.
Sleep apnea PAP devices have witnessed significant development in
terms of design, safety, and efficacy has helped to boost product adoption and
patient outcome. Moreover, miniaturization of PAP devices and availability of
cheaper brands is expected to fuel growth of the sleep apnea devices market
over the forecast period. Some of the key manufactur are BMC Medical Co. Ltd.;
GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.;
Cadwell Laboratories ResMed; Invacare Corporation; Braebon Medical Corporation;
ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.; Nihon
Kohden; and Compumedics Limited.
Access Research Report of Sleep Apnea Devices Market @ www.grandviewresearch.com/industry-analysis/sleep-apnea-devices-market
Further key findings from the report suggest:
· Therapeutic devices
segment led the market in 2018, with a revenue of USD 5,302.1 million, due to
high prevalence of OSA, increased treatment rate, patient adherence, and
availability of technologically advanced products
· Oral devices segment is
anticipated to exhibit the fastest CAGR of 11.7% over the forecast period as
these products offer higher patient outcome, lower economic burden, and higher
treatment adherence due to their smaller size
· Some of the key players
operating in the sleep apnea devices market are BMC Medical Co. Ltd.; GE
Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.;
Cadwell Laboratories; ResMed; Invacare Corporation; Braebon Medical
Corporation; ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.;
Nihon Kohden; and Compumedics Limited
Grand View Research has segmented the global sleep apnea devices
market on the basis of product and region:
Sleep Apnea Devices Product Outlook (Revenue, USD Million, 2014 -
2025)
·
Therapeutic Devices
·
PAP Devices
·
Oral Devices
·
Nasal Devices
·
Chin Straps
·
Diagnostic Devices
·
Actigraphs
·
Polysomnography
·
Respiratory Polygraphs
·
Pulse Oximeters
Sleep Apnea Devices Regional Outlook (Revenue, USD Million, 2014 -
2025)
·
North America
·
U.S.
·
Canada
·
Europe
·
Germany
·
U.K.
·
Spain
·
France
·
Italy
·
Russia
·
Asia Pacific
·
China
·
Japan
·
India
·
South Korea
·
Singapore
·
Australia
·
Latin America
·
Brazil
·
Mexico
·
Argentina
·
MEA
·
Tunisia
·
Egypt
·
South Africa
